| 12/31/2007 | CV | MGI Pharma subordinated notes to be convertible due to merger
|
| 12/10/2007 | CV | Market Commentary: WaMu bringing big deal; A&P watching P's & Q's; Millennium up on drug tests; MGI up on merger
|
| 12/10/2007 | CV | Market Commentary: WaMu bringing big deal; A&P watching P's & Q's; Millennium up on drug tests; MGI up on merger
|
| 11/29/2007 | CV | Market Commentary: E*Trade down on cash infusion; MGI Pharma up as options search begins; WCI falls with housing prices
|
| 7/20/2006 | CV | Market Commentary: Intel, Ford, Barnes fall on earnings weakness; New River quiet on debut; Essex plans $130 million deal
|
| 5/4/2006 | CV | Market Commentary: Bausch and Lomb up dollar-neutral on debt tenders; JDS Uniphase falls outright on poor guidance
|
| 5/3/2006 | CV | Market Commentary: Cephalon falls, PDL widens on results; NPS falls, MGI climbs on FDA news; XM firm despite lawsuits
|
| 2/8/2006 | CV | Market Commentary: Citadel retraces some gains; Qwest flat but adds on hedge; MGI better; Oil States lower; Pier 1 prices
|
| 1/19/2006 | CV | Market Commentary: Advanced Micro, Cypress gain, but Intel weaker; Hutchinson prices upsized $225 million deal
|
| 1/10/2006 | CV | Market Commentary: LifePoint Hospitals, MGI Pharma convertibles weaker on lower guidance; Cephalon jumps; GM mixed
|
| 11/29/2005 | BTCV | MGI Pharma gets tenders for $67.9 million Guilford convertibles
|
| 10/27/2005 | CV | Market Commentary: GM bonds lower, credit widens on bankruptcy scare; Digital River plunges; Par Pharma in
|
| 10/21/2005 | CV | Market Commentary: Wyeth holds up; Ford drops, but GM bonds move higher; Schlumberger off
|
| 10/20/2005 | BTCV | MGI Pharma tenders for newly acquired Guilford Pharmaceuticals convertible notes
|
| 10/20/2005 | CV | Market Commentary: Convertibles market reverses course after strong start; Cypress pulled down; Amgen, biotechs weaker
|
| 10/3/2005 | BTCV | MGI Pharma completes Guilford acquisition, plans to tender for convertibles
|
| 9/2/2005 | CV | Market Commentary: Albertson's mandatories lag as stock surges; Northwest Airlines, Delta weaken further
|
| 7/21/2005 | CV | Market Commentary: Cheniere Energy to price $300 million deal; selling hits convertibles as Treasuries slump
|
| 7/21/2005 | BTCV | MGI Pharma to "extinguish" Guilford Pharmaceuticals convertibles upon acquisition
|
| 9/1/2004 | CV | Market Commentary: Ford, GM slide on sales data, production cuts; MGI Pharma acquisitions move convertibles up
|
| 3/2/2004 | CV | MGI Pharma greenshoe exercised, raising convertibles to $260 million
|
| 2/26/2004 | CV | Market Commentary: Calpine slides on earnings; Toys R Us mandatory soars on stock upgrade; MGI up 0.25 point
|
| 2/26/2004 | CV | New Issue: MGI Pharma $225 million proceeds cash-to-zero converts at 2.25% yield, up 30%
|
| 2/25/2004 | CV | Market Commentary: Level 3 gains 2 points on massive credit spread blowout; Adelphia whipsaws, ends in 40s
|
| 2/24/2004 | CV | MGI Pharma $200 million proceeds discount cash-to-zero convert talked at 2.0-2.5% yield, up 30-35%
|
| 2/24/2004 | CV | Market Commentary: Calpine drops sharply after junk bond deal goes sour; BankUnited prices $100 million
|
